by Gordon Hensley | Mar 26, 2019 | advocacy, Business, GOP Politics, health care, lobbying, Pharmaceutical
This more of an addenda to my last post noting how PBMs have, to their detriment, ended up on Sen. Grassley’s radar screen. Now Sen. John Cornyn (R-TX), up for reelection this cycle, has weighed in: “The whole rebate thing just looks kind of — well...
by Gordon Hensley | Feb 21, 2019 | advocacy, Business, CMS, health care, lobbying, Medicare Cuts, Pharma, U.S. House, U.S. Senate
Among the most complex but significant issues in the unfolding debate about prescription drug pricing reform is pharmacy benefit manager (PBM) rebates — or, so-called “rebates” — as many objective observers see them as kickbacks or opaque...
by Gordon Hensley | Mar 10, 2018 | advocacy, Business, CMS, health care, Health Reform, Pharma, Trump
This week marked a true rarity for the Trump Administration: a coordinated, effective burst of reform-minded tough talk from three separate health policy leaders, in three consecutive days. In rat-tat-tat fashion, his HHS Secretary, CMS Administrator and FDA...
by Gordon Hensley | Mar 1, 2018 | advocacy, Business, CMS, health care, Pharma, SNF
It’s an election year. Congress has to appear to be “doing something” about the opioid epidemic engulfing communities across the U.S. The good news, it is: Senator Rob Portman (R-OH) introduced a bipartisan bill this week, the “CARA 2.0 Act of...
by Gordon Hensley | Jul 25, 2017 | advocacy, Business, health care
Axios published an excellent article this morning noting that smaller, Washington-based public affairs firms are going after business typically won by large agencies. “They lure clients with political expertise capable of handling crisis communications, and then...
by Gordon Hensley | Mar 20, 2017 | advocacy, GOP Politics, health care, Health Reform, Paul Ryan, Trump, U.S. House, U.S. Senate
This Thursday’s scheduled vote in the U.S. House of Representatives to begin rolling back Obamacare with the American Health Care Act will be Majority Whip Steve Scalise’s biggest, most important test to date. The Louisiana lawmaker’s star already on the rise,...
